Figure 1 (Argatroban Figure 1)
Argatroban Injection
Product Images NDC 16729-430
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 16729-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Argatroban Figure 2)
Figure 3 (Argatroban Figure 3)
This text appears to be a statistical report of a study with 147 participants, out of which 90 were censored. The study lasted for a maximum of 37 days and had a significant P value of 0.007. The asterisk indicates that there were no clinical endpoints, such as death or amputations.*
Figure 4 (Argatroban Figure 4)
Principal Display Panel (Carton Label)
This is a label of a medication named "Argatroban inosy" containing 50mg/50mL of the solution to be used solely for Intravenous Infusion. Each mL contains 1 mg of argatroban, 9 mg sodium chloride, USP and 3 mg sorbitol in water for injection, USP. It has a prescribed dosage for Adults. It should be stored at room temperature and should not be refrigerated or frozen. It comes in a Single Dose Vial and leftover portion must be discarded after administering. The label contains a 2D matrix size, lot number (EXP: MMM YYYY) and has instructions to keep the area unvarnished for pasting on it. The label also mentions the manufacturer of the medication.*
Principal Display Panel (Carton Label)
This text contains a mixture of gibberish characters, symbols, and alphanumeric codes. The only readable information is the name of a drug called "Argatroban" being injected intravenously without dilution. Dosage information is also included. No useful description can be generated from this text.*
Principal Display Panel (Vial Label)
This is a drug containing 1mg of argatroban, 9mg of sodium chloride, and 3mg of sorbiol in each ml. It is administered by intravenous infusion only and is available in a single-dose vial. It should not be used if the solution is cloudy or contains a precipitate. The drug should be stored at room temperature between 20°C to 25°C (68°F to 77°F) and protected from light. Dilution prior to administration is not recommended. The usual adult dosage should be referred from the prescribing information.*
Structural Formula (Argatroban Structural Formula)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
